Microbiologic study of the respiratory tract in children with cystic fibrosis;ESTUDIO MICROBIOLOGICO DEL TRACTO RESPIRATORIO EN NINOS AFECTADOS DE FIBROSIS QUISTICA

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 14, Issue 3, 1996, Pages 142-144

  Muñoz, Carmen ^a   Juncosa, Teresa ^a   Gené, Amadeo ^a   Fortea, Josep ^a   Séculi, José Luis ^a   Latorre, Cristina ^a  

^a HOSPITAL SANT JOAN DE DÉU   (Spain)

Author keywords

cystic fibrosis; Haemophilus influenzae; Pseudomonas aeruginosa

Indexed keywords

ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; HAEMOPHILUS INFLUENZAE; HUMAN; MALE; OPPORTUNISTIC INFECTION; PERSISTENT INFECTION; PSEUDOMONAS AERUGINOSA; RESPIRATORY SYSTEM; SPAIN; ADOLESCENT; BACTERIUM; INFANT; ISOLATION AND PURIFICATION; MICROBIOLOGY; PRESCHOOL CHILD; PROSPECTIVE STUDY; SPUTUM;

ADOLESCENT; BACTERIA; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; FEMALE; HUMANS; INFANT; MALE; PROSPECTIVE STUDIES; RESPIRATORY SYSTEM; SPUTUM;

EID: 0030094399     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. a ed. Mexico: Interamericana McGraw-Hill, 1987; 1.336-1.339.
2. Kerrebijn KF, Michel MF, Horrevorts AM. Pulmonary Infection and Antibiotic Treatment in Cystic Fibrosis. Chest 1988; 94 (2 pt 2): 97s.
3. Guilligan PH. Microbiology of airway disease in patients with cystic fibrosis. Clin Microbiol Rev 1991; 4 (1): 35-51.
4. Doern GV, Brogden-Torres B. Optimun use of selective plate media in primary processing of respiratory tract specimens from patients with cystic fibrosis. J Clin Microbiol 1992; 30 (10): 2.740-2.742.
5. Kronborg G, Hansen MB, Svenson M. Cytokines in Sputum and Serum From Patients With Cystic Fibrosis and Chronic Pseudomonas aeruginosa Infection as Markers of destructive Inflammation in the lungs. Pediatr Pulmonol 1993; 15 (5): 292-297.
6. Cahen P, Le Bourgeois M, Delacourt C. Serum Bactericidal Test as a Prognostic Indicator in Acute Pulmonary Exacerbations of Cystic Fibrosis. Pediatrics 1993; 91 (2): 451-455.
7. Brett MM, Simmonds EJ, Ghoneim AT. The value of serum IgG titres against Pseudomonas aeruginosa in the management of early pseudomonal infection in cystic fibrosis. Arch Dis Child 1992; 67 (9): 1.086-1.089.
8. Rusell NJ, Gacesa P. Physicochemical properties of alginate form mucoid strains of Pseudomonas aeruginosa. Antibiot Chemother 1989; 42: 62-66.
9. Ferrer A, Tórtola MT, González T. Bacteriología de la mucoviscidosis durante un período de 5 años. Enferm Infecc Microbiol Clin 1992; 10 (1): 34-38.
10. Ojeda-Vargas M. Fibrosis quística: Perspectivas e implicaciones microbiológicas. Rev Esp Microbiol Clin 1990; 5 (4): 187-188.
11. Haemophilus influenzae, Staphylococcus aureus, Pseudomonas cepacea, and Pseudomonas aeruginosa in patients with Cystic Fibrosis. Chest 1988; 94 (2 pt 2): 97s-103s.
12. Bauernfeind A, Horl G, Przyklenk B. Microbiologic and therapeutic aspects of Staphylococcus aureus in cystic fibrosis patients. Scand J Gastroenterol 1988 Supl 143: 99-102.
13. Bauerfind A, Bertele RM, Harms K. Qualitative and quantitative microbiological analysis of sputa of 102 patients with cystic fibrosis. Infection 1987; 15: 270-277.
14. Corey M, Allison L, Prober C. Sputum bacteriology in patients with cystic fibrosis in a Toronto Hospital during 1970-1981. J Infect Dis 1984; 149: 283.
15. Hoiby N, Friis B, Jensen K. Antimicrobial chemotherapy in cystic fibrosis patients. Acta Paediatr Scand 1982; 301 Supl: 75-100.
16. De Montalembert M, Berche P, Lenoir G. Traitement antibiotique de la mucoviscidose. Ann Pediatr (Paris) 1991; 38 (8): 523-528.
17. Lietman PS. Pharmacokinetics of Antimicrobial Drugs in Cystic Fibrosis. Chest 1988; 94 (2 pt 2): 115s-119s.